Issues related to - OECD proposals on global tax & implementation and/or related Presidential executive orders - corporate tax provisions in OBBB
2025 · 3rd Quarter (July 1 - Sep 30)
JOHNSON & JOHNSON SERVICES INC
Filed by JOHNSON & JOHNSON SERVICES, INC..
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2025
- Income
- Not reported
- Expenses
- $2,480,000.00
- Registrant
- JOHNSON & JOHNSON SERVICES, INC.
- Filing UUID
- 3f159806-92d3-4974-9af8-39758f1c8fb0
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Issues related to: - Veterans Administration and Veterans Health Administration procurement and contracting processes for medical technology - VA Program
- Issues related to USMCA review and renegotiation
- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - obesity treatments - MFN - Foreign Reference Pricing
Literal federal measure citations: H.R. 1539, H.R. 929, S. 266, H.R. 946, S.864, H.R. 2214, H.R. 1492, S. 832, S. 1954, H.R. 5526, H.R.2527, H.R.5343, S. 1717, H.R.4282, H.R. 4299, H.Res. 1301
- Issues related to stroke care
- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions - H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act, regarding all provisions - S.2658, Medication Affordability and Patent Integrity Act Issues related to: - intellectual property, including S. 1040, a bill to amend the Federal Trade Commission Act to prohibit product hopping - patent thickets - patent fees
Literal federal measure citations: S. 1040, S. 1041, S. 1097, H.R. 3269, S. 2276, S.2658, S. 1040
Issues related to - H.R. 1109, the Litigation Transparency Act of 2025, and transparency in domestic third-party litigation funding - H.R.2675, Protecting Our Courts from Foreign Manipulation Act, and transparency in foreign third-party litigation funding
- Issues related to the SUPPORT Act
Issues related to - artificial intelligence - data privacy - cybersecurity - robotics
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.